Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
6.970
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
6.970
Bid (Size)
6.660 (118)
Ask (Size)
8.280 (2)
Prev. Close
6.970
Today's Range
6.970 - 6.970
52wk Range
4.135 - 9.370
Shares Outstanding
412,429,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
GOODRX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm
April 23, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
April 23, 2024
From
Schall Law
Via
GlobeNewswire
Performance
YTD
+24.02%
+24.02%
1 Month
-1.41%
-1.41%
3 Month
+4.19%
+4.19%
6 Month
+26.73%
+26.73%
1 Year
+23.14%
+23.14%
More News
Read More
GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
April 23, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Why GoodRx Surged Today
March 25, 2024
Via
The Motley Fool
The Latest Analyst Ratings For GoodRx Holdings
March 25, 2024
Via
Benzinga
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
April 23, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
April 22, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
February 26, 2024
Via
Benzinga
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
April 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
April 10, 2024
Via
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
March 25, 2024
Via
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Via
Benzinga
GoodRx Interim CEO Extends Commitment to Company
March 14, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
March 01, 2024
Via
Benzinga
Why GoodRx Stock Soared Today
February 29, 2024
Via
The Motley Fool
GoodRx (GDRX) Q4 2023 Earnings Call Transcript
February 29, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Is Telemedicine Firm GoodRx's Shares Surging Today
February 29, 2024
Via
Benzinga
GoodRx Reports Fourth Quarter and Full Year 2023 Results
February 29, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
This healthcare stock making a buzz with 160% growth
February 26, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
GoodRx to Participate in Upcoming Investor Conferences
February 20, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Via
MarketBeat
Exposures
Product Safety
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
February 01, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.